These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26101933)

  • 21. Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity.
    Shapiro MB; Cheever T; Malherbe DC; Pandey S; Reed J; Yang ES; Wang K; Pegu A; Chen X; Siess D; Burke D; Henderson H; Lewinsohn R; Fischer M; Stanton JJ; Axthelm MK; Kahl C; Park B; Lewis AD; Sacha JB; Mascola JR; Hessell AJ; Haigwood NL
    Nat Commun; 2020 Jan; 11(1):70. PubMed ID: 31911610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards an HIV-1 vaccine: lessons from studies in macaque models.
    Hulskotte EG; Geretti AM; Osterhaus AD
    Vaccine; 1998; 16(9-10):904-15. PubMed ID: 9682336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection.
    Kwofie TB; Miura T; Ibuki K; Enose Y; Suzuki H; Ui M; Kuwata T; Hayami M
    Arch Virol; 2002 Jun; 147(6):1091-104. PubMed ID: 12111421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs.
    Ui M; Kuwata T; Igarashi T; Ibuki K; Miyazaki Y; Kozyrev IL; Enose Y; Shimada T; Uesaka H; Yamamoto H; Miura T; Hayami M
    Virology; 1999 Dec; 265(2):252-63. PubMed ID: 10600597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4+ T-cell subsets: what really counts in preventing HIV disease?
    Mason RD; De Rose R; Kent SJ
    Expert Rev Vaccines; 2008 Mar; 7(2):155-8. PubMed ID: 18324885
    [No Abstract]   [Full Text] [Related]  

  • 26. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity.
    Kent SJ; Fernandez CS; Dale CJ; Davenport MP
    Trends Microbiol; 2005 Jun; 13(6):243-6. PubMed ID: 15936652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral immunity to HIV, SIV, and SHIV.
    Haigwood NL; Zolla-Pazner S
    AIDS; 1998; 12 Suppl A():S121-32. PubMed ID: 9632993
    [No Abstract]   [Full Text] [Related]  

  • 28. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants.
    Klein F; Nogueira L; Nishimura Y; Phad G; West AP; Halper-Stromberg A; Horwitz JA; Gazumyan A; Liu C; Eisenreich TR; Lehmann C; Fätkenheuer G; Williams C; Shingai M; Martin MA; Bjorkman PJ; Seaman MS; Zolla-Pazner S; Karlsson Hedestam GB; Nussenzweig MC
    J Exp Med; 2014 Nov; 211(12):2361-72. PubMed ID: 25385756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.
    Subbarao S; Otten RA; Ramos A; Kim C; Jackson E; Monsour M; Adams DR; Bashirian S; Johnson J; Soriano V; Rendon A; Hudgens MG; Butera S; Janssen R; Paxton L; Greenberg AE; Folks TM
    J Infect Dis; 2006 Oct; 194(7):904-11. PubMed ID: 16960777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid CD4+ T-lymphocyte depletion in rhesus monkeys infected with a simian-human immunodeficiency virus expressing the envelope glycoproteins of a primary dual-tropic Ethiopian Clade C HIV type 1 isolate.
    Cayabyab M; Rohne D; Pollakis G; Mische C; Messele T; Abebe A; Etemad-Moghadam B; Yang P; Henson S; Axthelm M; Goudsmit J; Letvin NL; Sodroski J
    AIDS Res Hum Retroviruses; 2004 Jan; 20(1):27-40. PubMed ID: 15000696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An HIV-1 infection-related idiotype/clonotype (1F7) is expressed on antibodies directed to envelope glycoprotein in simian immunodeficiency virus- and chimeric simian/human immunodeficiency virus-infected rhesus monkeys.
    Müller S; Margolin DH; Min G
    Hybridoma; 1997 Feb; 16(1):17-21. PubMed ID: 9085123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
    Veazey RS; Klasse PJ; Schader SM; Hu Q; Ketas TJ; Lu M; Marx PA; Dufour J; Colonno RJ; Shattock RJ; Springer MS; Moore JP
    Nature; 2005 Nov; 438(7064):99-102. PubMed ID: 16258536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insights into evaluating effective T-cell responses to HIV.
    Allen TM; Watkins DI
    AIDS; 2001; 15 Suppl 5():S117-26. PubMed ID: 11816159
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
    Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
    AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease.
    Song B; Cayabyab M; Phan N; Wang L; Axthelm MK; Letvin NL; Sodroski JG
    Virology; 2004 Apr; 322(1):168-81. PubMed ID: 15063126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV.
    Zhan X; Martin LN; Slobod KS; Coleclough C; Lockey TD; Brown SA; Stambas J; Bonsignori M; Sealy RE; Blanchard JL; Hurwitz JL
    Vaccine; 2005 Nov; 23(46-47):5306-20. PubMed ID: 16095768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The acute HIV infection: implications for intervention, prevention and development of an effective AIDS vaccine.
    Nishimura Y; Martin MA
    Curr Opin Virol; 2011 Sep; 1(3):204-10. PubMed ID: 21909345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
    Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
    Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in simian--human immunodeficiency viruses for nonhuman primate studies of HIV prevention and cure.
    Bauer AM; Bar KJ
    Curr Opin HIV AIDS; 2020 Sep; 15(5):275-281. PubMed ID: 32769631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.